Guidance to detect, evaluate and prevent the problem of selective reporting in trial publications by Kerry Dwan et al.
ORAL PRESENTATION Open Access
Guidance to detect, evaluate and prevent
the problem of selective reporting in
trial publications
Kerry Dwan1*, Paula R Williamson1, Carrol Gamble1, Julian Higgins2, Jonathan Sterne2, Douglas G Altman3,
Mike Clarke4, Jamie J Kirkham1
From 2nd Clinical Trials Methodology Conference: Methodology Matters
Edinburgh, UK. 18-19 November 2013
Background
Many aspects of a trial may be incompletely reported,
including the outcomes collected and the full set of ana-
lyses undertaken. Selective reporting bias occurs when
the inclusion of outcomes or analyses in the report is
based on the results. We review and summarise the
empirical evidence from studies that have assessed the
selective reporting of outcomes and analyses and pro-
vide guidance to trialists to help reduce this problem.
Methods
Two systematic reviews of studies that have examined
randomised trials for i) evidence for publication bias or
selective reporting of outcomes and ii) evidence for selec-
tive reporting of analyses. An international collaboration
of experts will be brought together in July to discuss the
available evidence alongside current reporting guidance
for trials. Recommendations are being produced with
regards to raising the awareness and safeguarding trial
publications against selective reporting.
Results
From twenty studies, of which four were newly identi-
fied, the evidence in the first systematic review demon-
strated an association between statistically significant
results and publication. Statistically significant outcomes
had a higher odds of being fully reported compared to
non-significant outcomes (range of odds ratios: 2.2
to 4.7). A further seventeen studies consider aspects of
selective reporting such as statistical analyses; subgroup
analyses and composite outcomes.
Conclusions
This work highlights the evidence of selective reporting
and demonstrates the importance of pre-specifying out-
comes, analyses and reporting strategies during the
planning and design of a clinical trial, for the purposes
of minimising bias when findings are reported.
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